Brii Biosciences Ltd
HKEX:2137
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Brii Biosciences Ltd
HKEX:2137
|
CN |
|
C
|
Cohort PLC
F:C7K
|
UK |
|
Unite Group PLC
LSE:UTG
|
UK |
|
RLX Technology Inc
NYSE:RLX
|
CN |
|
P
|
Pacific Biosciences of California Inc
SWB:P09
|
US |
|
T
|
Trustmark Corp
F:TT4
|
US |
|
APA Corp (US)
LSE:0HGC
|
US |
|
Grupo Aeroportuario del Sureste SAB de CV
OTC:ASRMF
|
MX |
Shareholder Yield
Current shareholder yield for Brii Biosciences Ltd is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Brii Biosciences Ltd
| Average Annual Return | -40.29% |
| Standard Deviation of Annual Returns | 47.24% |
| Max Drawdown | -98% |
| Market Capitalization | 620.2m HKD |
| Shares Outstanding | 721 850 000 |
| Percentage of Shares Shorted |
N/A
|
